What Is Cytoreductive Surgery?
Cytoreductive surgery — also called debulking surgery — is the surgical removal of as much tumour as possible from the abdominal and pelvic cavity. In ovarian cancer, the goal is to leave no visible residual disease (complete cytoreduction, or R0). This is not a simple hysterectomy — it is a complex, multi-organ procedure that may involve removal of the uterus, ovaries, omentum, peritoneum, appendix, sections of bowel, spleen, and even parts of the diaphragm.
Why Complete Cytoreduction Matters
The volume of residual disease after surgery is the single most important prognostic factor in advanced ovarian cancer. Multiple large studies have demonstrated that women who undergo complete cytoreduction (no visible residual tumour) have significantly longer survival than those left with any macroscopic disease. This is why the experience and training of the operating surgeon directly affects patient outcomes.
What the Surgery Involves
A typical cytoreductive procedure for advanced ovarian cancer may include some or all of the following:
- Total abdominal hysterectomy and bilateral salpingo-oophorectomy
- Infragastric omentectomy
- Pelvic and para-aortic lymphadenectomy
- Peritoneal stripping (pelvic sidewalls, paracolic gutters, diaphragm)
- Rectosigmoid resection (if the recto-uterine pouch is involved)
- Splenectomy (if splenic hilum disease is present)
- Appendicectomy
- Liver surface resection
This is not a procedure that a general gynaecologist is trained to perform. Cytoreductive surgery for ovarian cancer requires a fellowship-trained gynaecological oncosurgeon working within a multidisciplinary team that includes colorectal surgeons, anaesthesiologists with oncology experience, and intensive care support.
Primary vs. Interval Cytoreduction
Primary cytoreduction is performed before any chemotherapy, directly at the time of diagnosis. Interval cytoreduction follows 3 cycles of neoadjuvant chemotherapy, which shrinks the tumour burden and may allow a more complete surgical result in patients with very extensive disease. Both approaches achieve comparable survival outcomes when performed by experienced surgeons — the choice depends on clinical assessment.
For a consultation about cytoreductive surgery for ovarian cancer in Ahmedabad, contact Dr. Nishtha Tripathi Patel: +91 76988 00333.